SpherIngenics Email Format
Biotechnology ResearchGeorgia, United States0-1 Employees
SpherIngenics (SPi) operates in the biotechnology research sector, focusing on the development and production of its patented microbeads. These alginate-based beads are designed to localize cells precisely at targeted sites after injection, with the aim of improving the viability of encapsulated cell therapies and enhancing tissue regeneration through increased therapeutic factor secretion. The company targets medical applications that benefit from localized cell delivery and sustained tissue support, providing a potential advantage in tissue repair and regeneration contexts. Based in Atlanta, Georgia, SPi presents itself as a small-scale operation in the biotech landscape, with a development focus on advancing its microbead technology and its therapeutic implications.